Cargando…

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy

INTRODUCTION: Immunotherapy may be an excellent choice for treating osteosarcoma given its exceptionally high genomic instability, potentially generating neoantigens. In this study, we aim to investigate the HLA class I expression, PD-L1 and tumour-infiltrating lymphocytes in primary osteosarcomas a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundara, Yayan T., Kostine, Marie, Cleven, Arjen H. G., Bovée, Judith V. M. G., Schilham, Marco W., Cleton-Jansen, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222929/
https://www.ncbi.nlm.nih.gov/pubmed/27853827
http://dx.doi.org/10.1007/s00262-016-1925-3
_version_ 1782493084498526208
author Sundara, Yayan T.
Kostine, Marie
Cleven, Arjen H. G.
Bovée, Judith V. M. G.
Schilham, Marco W.
Cleton-Jansen, Anne-Marie
author_facet Sundara, Yayan T.
Kostine, Marie
Cleven, Arjen H. G.
Bovée, Judith V. M. G.
Schilham, Marco W.
Cleton-Jansen, Anne-Marie
author_sort Sundara, Yayan T.
collection PubMed
description INTRODUCTION: Immunotherapy may be an excellent choice for treating osteosarcoma given its exceptionally high genomic instability, potentially generating neoantigens. In this study, we aim to investigate the HLA class I expression, PD-L1 and tumour-infiltrating lymphocytes in primary osteosarcomas and relapses/metastases, as well as their changes during disease progression. MATERIALS AND METHODS: Tumour samples from multiple stages of the disease (pretreatment biopsies, surgical resections of primary osteosarcomas, relapses and metastases) were collected and stained for HLA-A (HCA2), HLA-B/C (HC10), β2-microglobulin and PD-L1 using immunohistochemistry on whole sections. Density and type of T-cell infiltrate were characterised by a triple immunofluorescent staining CD3-CD8-FOXP3. RESULTS: Overall, 85 formalin-fixed, paraffin-embedded blocks from 25 osteosarcoma patients were included. HLA class I expression was detected in 94% of osteosarcomas (strongly positive in 56%, heterogeneous in 38%) and negative or weakly positive in 6%, without differences between the stages of the disease. HLA-A expression was more frequently negative than HLA-B/C. Tumour-infiltrating lymphocytes were highly heterogeneous and mainly observed in tumour areas with expression of HLA class I. Density of T cells was significantly higher in metastases than in primary tumours and local relapses (p = 0.0003). Positive PD-L1 expression was found in 13% of primary tumours, 25% of relapses and 48% of metastases and correlated with a high T-cell infiltrate (p = 0.002). CONCLUSION: An increased number of tumour-infiltrating T cells and PD-L1 expression in metastases compared with primary tumours, suggesting accessibility for T cells, could imply that osteosarcoma patients with metastatic disease may benefit from T-cell-based immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-016-1925-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5222929
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-52229292017-01-19 Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy Sundara, Yayan T. Kostine, Marie Cleven, Arjen H. G. Bovée, Judith V. M. G. Schilham, Marco W. Cleton-Jansen, Anne-Marie Cancer Immunol Immunother Original Article INTRODUCTION: Immunotherapy may be an excellent choice for treating osteosarcoma given its exceptionally high genomic instability, potentially generating neoantigens. In this study, we aim to investigate the HLA class I expression, PD-L1 and tumour-infiltrating lymphocytes in primary osteosarcomas and relapses/metastases, as well as their changes during disease progression. MATERIALS AND METHODS: Tumour samples from multiple stages of the disease (pretreatment biopsies, surgical resections of primary osteosarcomas, relapses and metastases) were collected and stained for HLA-A (HCA2), HLA-B/C (HC10), β2-microglobulin and PD-L1 using immunohistochemistry on whole sections. Density and type of T-cell infiltrate were characterised by a triple immunofluorescent staining CD3-CD8-FOXP3. RESULTS: Overall, 85 formalin-fixed, paraffin-embedded blocks from 25 osteosarcoma patients were included. HLA class I expression was detected in 94% of osteosarcomas (strongly positive in 56%, heterogeneous in 38%) and negative or weakly positive in 6%, without differences between the stages of the disease. HLA-A expression was more frequently negative than HLA-B/C. Tumour-infiltrating lymphocytes were highly heterogeneous and mainly observed in tumour areas with expression of HLA class I. Density of T cells was significantly higher in metastases than in primary tumours and local relapses (p = 0.0003). Positive PD-L1 expression was found in 13% of primary tumours, 25% of relapses and 48% of metastases and correlated with a high T-cell infiltrate (p = 0.002). CONCLUSION: An increased number of tumour-infiltrating T cells and PD-L1 expression in metastases compared with primary tumours, suggesting accessibility for T cells, could imply that osteosarcoma patients with metastatic disease may benefit from T-cell-based immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-016-1925-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-11-16 2017 /pmc/articles/PMC5222929/ /pubmed/27853827 http://dx.doi.org/10.1007/s00262-016-1925-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Sundara, Yayan T.
Kostine, Marie
Cleven, Arjen H. G.
Bovée, Judith V. M. G.
Schilham, Marco W.
Cleton-Jansen, Anne-Marie
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
title Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
title_full Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
title_fullStr Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
title_full_unstemmed Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
title_short Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
title_sort increased pd-l1 and t-cell infiltration in the presence of hla class i expression in metastatic high-grade osteosarcoma: a rationale for t-cell-based immunotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222929/
https://www.ncbi.nlm.nih.gov/pubmed/27853827
http://dx.doi.org/10.1007/s00262-016-1925-3
work_keys_str_mv AT sundarayayant increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy
AT kostinemarie increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy
AT clevenarjenhg increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy
AT boveejudithvmg increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy
AT schilhammarcow increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy
AT cletonjansenannemarie increasedpdl1andtcellinfiltrationinthepresenceofhlaclassiexpressioninmetastatichighgradeosteosarcomaarationalefortcellbasedimmunotherapy